| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 03/25/2003 | US6537987 4,1-benzoxazepines or 4,1-benzothiazepines and their use as squalene synthetase inhibitors |
| 03/25/2003 | US6537986 Oxazolidinone antibacterial agents having a thiocarbonyl funtionality |
| 03/25/2003 | CA2423800A1 Fused cyclic compounds and medicinal use thereof |
| 03/21/2003 | WO2002026230A1 Remedies for inflammatory bowel diseases |
| 03/21/2003 | CA2423423A1 Medecines of ulcerative colitis |
| 03/20/2003 | WO2003022844A2 Synthesis of epothilones intermediates thereto and analogues thereof |
| 03/20/2003 | WO2003022842A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors |
| 03/20/2003 | WO2003022839A1 Tetrahydropyran derivatives and their use as therapeutic agents |
| 03/20/2003 | WO2003022824A1 Oxazolidinone and/or isoxazoline as antibacterial agents |
| 03/20/2003 | WO2003022814A1 Indole derivatives |
| 03/20/2003 | WO2003022813A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 03/20/2003 | WO2003022806A2 Cbi analogues of cc-1065 and the duocarmycins |
| 03/20/2003 | WO2003022280A2 3-glyoxlylamideindoles for treating cancer |
| 03/20/2003 | WO2003022274A2 2-aroylimidazole compounds for treating cancer |
| 03/20/2003 | WO2003022273A1 Methods of treating cytokine mediated diseases |
| 03/20/2003 | WO2002100845A8 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 03/20/2003 | WO2002074758A3 Novel amines as histamine-3 receptor ligands and their therapeutic applications |
| 03/20/2003 | WO2002067865A3 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 03/20/2003 | US20030055266 Small molecule modulators of G protein-coupled receptors |
| 03/20/2003 | US20030055265 Oxazole derivatives |
| 03/20/2003 | US20030055261 Compounds with growth hormone releasing properties |
| 03/20/2003 | US20030055244 Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| 03/20/2003 | US20030055087 As analgesic |
| 03/20/2003 | US20030055085 For therapy of stroke, head trauma, anoxic injury, ischemic injury, hypoglycemia, epilepsy, pain, migraine headaches, Parkinson's disease, senile dementia, Huntington's Chorea, anxiety, and Alzheimer's disease |
| 03/20/2003 | US20030055068 Pyrazole compounds useful as protein kinase inhibitors |
| 03/20/2003 | US20030055057 1-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharmaceutial agents as well as pharmaceutical preparations that contain these derivatives |
| 03/20/2003 | US20030055055 For inducing and maintaining anesthesia, sedation and muscle relaxation, as well as for combating febrile convulsions in children |
| 03/20/2003 | US20030055054 CXCR3 antagonists |
| 03/20/2003 | US20030055044 Administering pyrazole derivative for inhibiting GSK-3 or Aurora activity in a patient |
| 03/20/2003 | US20030055039 For prophylaxis and therapy of inflammatory disease |
| 03/20/2003 | US20030055012 Prodrugs of COX-2 inhibitors |
| 03/20/2003 | US20030054974 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 03/20/2003 | CA2460347A1 3-glyoxlylamideindoles for treating cancer |
| 03/20/2003 | CA2460345A1 2-aroylimidazole compounds for treating cancer |
| 03/20/2003 | CA2459882A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors |
| 03/20/2003 | CA2459766A1 Oxazolidinone and/or isoxazoline as antibacterial agents |
| 03/20/2003 | CA2459515A1 Indole derivatives |
| 03/20/2003 | CA2459464A1 Tetrahydropyran derivatives and their use as therapeutic agents |
| 03/20/2003 | CA2459308A1 Cbi analogues of cc-1065 and the duocarmycins |
| 03/20/2003 | CA2458029A1 Methods of treating cytokine mediated diseases |
| 03/19/2003 | EP1293503A1 Triazole derivatives |
| 03/19/2003 | EP1292594A1 Quinazoline derivatives for the treatment of tumours |
| 03/19/2003 | EP1292593A2 2-(3,5-disubstituted-4-pyridyl)-4-(thienyl, thiazolyl or arylphenyl)-1,3-oxazoline compounds |
| 03/19/2003 | EP1292591A2 Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 03/19/2003 | EP1292585A1 Benzoxazepinones and their use as squalene synthase inhibitors |
| 03/19/2003 | EP1292579A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 03/19/2003 | EP1292574A1 3-azabicyclo[3.1.0]hexane derivatives having opioid receptor affinity |
| 03/19/2003 | EP1292573A2 Substituted thioacetamides |
| 03/19/2003 | EP1157019B1 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2 |
| 03/19/2003 | EP0934312B1 1,4-disubstituted piperazines |
| 03/19/2003 | CN1404481A Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes |
| 03/19/2003 | CN1404478A Pyridinylimidazoles |
| 03/19/2003 | CN1404472A Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 03/19/2003 | CN1404470A 2-OXo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 03/19/2003 | CN1404469A 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 03/19/2003 | CN1404390A TNF-alpha inhibitors |
| 03/19/2003 | CN1403455A Synthesis of 2-oxazolidone derivate by one still process |
| 03/19/2003 | CN1403453A Quinoline and quinazoline compound for treating benign prostatic hyperplasia specially |
| 03/19/2003 | CN1103338C Heterocyclic compound for treating myocardial ischaemia |
| 03/19/2003 | CN1103336C Process for producing unsymmetrical 4,6-bis (aryloxy) pyrimidine compound |
| 03/18/2003 | US6535943 Information processing device enabling floating interrupt to be pending and a method executing an interrupt condition change instruction |
| 03/18/2003 | US6534658 Intermediates for producing pharmaceuticals |
| 03/18/2003 | US6534535 Inhibitors of factor Xa |
| 03/18/2003 | US6534509 Derivatives are useful as anti-inflammatory agents. This invention is also directed to pharmacetutical compostions for inflammation |
| 03/18/2003 | US6534496 Prophylactic and/or therapeutic drug for obesity and obesity associated diseasestor diabetes with a reduced risk for central side effects and high universality in usage. Another object of the a lipolytic agent, or a prophylactic and/or |
| 03/18/2003 | CA2268028C 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds |
| 03/18/2003 | CA2217351C Carbonyl-piperazinyl and piperidinyl compounds which inhibit farnesyl protein transferase |
| 03/13/2003 | WO2004043335A2 Methods of treating infection by drug resistant bacteria |
| 03/13/2003 | WO2003020707A1 Optical isomers of an iloperidone metabolite |
| 03/13/2003 | WO2003020271A1 Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents |
| 03/13/2003 | WO2003020270A1 Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents |
| 03/13/2003 | WO2003020269A1 Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators |
| 03/13/2003 | WO2002096361A3 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors |
| 03/13/2003 | WO2002096359A3 Piperazine pentanamide hiv protease inhibitors |
| 03/13/2003 | WO2002096317A3 Method for treating glaucoma vi |
| 03/13/2003 | WO2002076950A3 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors |
| 03/13/2003 | WO2002068388A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 03/13/2003 | WO2002066469A3 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands |
| 03/13/2003 | WO2002036554A3 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 03/13/2003 | WO2002036553A3 Substituted alkanoic acids |
| 03/13/2003 | US20030050477 Reacting a 2-halo-3-(pyrazol-3-yl)anilide derivative in presence of a transition metal compound of sub gruop VIIa and VIIIa or Ib of periodic table and a base to form the 7-(pyrazol-3-yl)benzoxazole derivative |
| 03/13/2003 | US20030050320 A therapeutic agent for treating hepatitis C, based on polymerase inhibitory activity |
| 03/13/2003 | US20030050315 An inhibitors of trypsin-like serine protease enzymes, as anticoagulant agents for treatment and prevention of thromboembolic disorders |
| 03/13/2003 | US20030050311 A novel phenyl oxazoles, thiazoles, oxazolines, oxadiazoles or benzoxazoles for treating neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, amytrophic lateral sclerosis or cerebral trauma |
| 03/13/2003 | US20030050309 A gelatinase inhibitor for modulating the activity of a dopamine, serotonin, or norepinephrine receptor or transporter |
| 03/13/2003 | US20030050301 A drug mixture additionally comprising an antihypertensive agent or it's prodrug and a carrier, vehicle or diluent |
| 03/13/2003 | CA2459376A1 Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents |
| 03/13/2003 | CA2459375A1 Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents |
| 03/13/2003 | CA2458926A1 Methods of treating infection by drug resistant bacteria |
| 03/12/2003 | EP1291346A1 Process for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties |
| 03/12/2003 | EP1289984A1 Novel oxazolidinone derivatives and a process for the preparation thereof |
| 03/12/2003 | EP1289983A2 Heteroarylalkanoic acids as integrin receptor antagonists |
| 03/12/2003 | EP1289982A1 Bioisosteric benzamide derivatives and their use as apob-100 secretion inhibitors |
| 03/12/2003 | EP1289980A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides |
| 03/12/2003 | EP1289965A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 03/12/2003 | EP1289964A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 03/12/2003 | EP1289960A2 Cycloalkyl alkanoic acids as integrin receptor antagonists |
| 03/12/2003 | EP1289957A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 03/12/2003 | EP1289956A1 Chemical compounds |
| 03/12/2003 | EP1289955A1 Piperidines for use as orexin receptor antagonists |